{"id":"W3091971999","doi":"10.1186/s12931-020-01503-z","title":"SOURCE: a phase 3, multicentre, randomized, double-blind, placebo-controlled, parallel group trial to evaluate the efficacy and safety of tezepelumab in reducing oral corticosteroid use in adults with oral corticosteroid dependent asthma","year":2020,"lang":"en","type":"article","venue":"Respiratory Research","topic":"Asthma and respiratory diseases","field":"Medicine","cited_by":90,"is_retracted":false,"has_abstract":true,"ca_institutions":"AstraZeneca (Canada)","funders":"AstraZeneca; Amgen","keywords":"Medicine; Asthma; Exacerbation; Placebo; Adverse effect; Corticosteroid; Randomized controlled trial; Internal medicine","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.005961863,0.0005034612,0.002028707,0.0007004286,0.0002249605,0.0001644043,0.0004042279,0.0002219407,0.00009578207],"category_scores_gemma":[0.004360985,0.0003113372,0.0002456529,0.001183569,0.0006901525,0.0002949233,0.0003627678,0.001270733,0.00003138555],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002469322,"about_ca_system_score_gemma":0.0008086411,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0003795148,"about_ca_topic_score_gemma":0.000881313,"domain_scores_codex":[0.990026,0.003787236,0.001863984,0.001092482,0.002121235,0.001109068],"domain_scores_gemma":[0.9949588,0.002443379,0.0003006516,0.0007686577,0.0005156334,0.001012832],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9703234,0.001949886,0.005586904,0.0002551305,0.0002098845,0.0004336889,0.00264035,0.00131427,0.002468124,0.00001089692,0.00006340284,0.01474401],"study_design_scores_gemma":[0.9788568,0.008137969,0.002953142,0.0009226302,0.0001898562,0.00001900765,0.001611204,0.005928874,0.0003620151,0.000001607977,0.0006952306,0.0003216358],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9769295,0.001395228,0.0002254542,0.0006945201,0.00006841538,0.02055849,0.00001974902,0.00004233946,0.00006633795],"genre_scores_gemma":[0.9974003,0.00007766218,0.0001346401,0.0007093834,0.0002118079,0.00129788,0.0000165387,0.00008476285,0.00006704985],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.02047081,"threshold_uncertainty_score":0.9999339,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.09572569561784532,"score_gpt":0.3849696708320763,"score_spread":0.289243975214231,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}